Abstract

Intracranial hemorrhages associated with new generation left ventricular assist devices (LVAD) are increasingly reported as the use of these life saving devices is becoming more common, but few data are currently available to guide the acute management of these critically ill patients. This is a case presentation of a 33-year-old woman status post LVAD implantation on therapeutic anticoagulation who developed acute headache followed by rapidly progressive impairment of consciousness secondary to spontaneous subarachnoid hemorrhage and hydrocephalus. After discontinuation of heparin infusion, the patient underwent external ventricular drain placement(EVD)and her mental status fully recovered. Her work-up was negative for aneurysmal sources of bleeding. She received daily aspirin for 7 days for antiplatelet effect during which she did not experience any thromboembolic events related to the LVAD. At day 6 the EVD was clamped for 24 hours and her neurological exam remained intact. The EVD was removed and she was restarted on heparin infusion without further complications. Our experience suggests that in case of subarachnoid hemorrhage in patients with LVADs, temporary suspension of anticoagulation and EVD placement is safe and can lead to good neurological outcome.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.